Pasithea Therapeutics Corp (KTTA)
NASDAQ:KTTA
US Market
Holding KTTA?
Track your performance easily

Pasithea Therapeutics Corp (KTTA) Financial Statements

32 Followers

Pasithea Therapeutics Corp Financial Overview

Pasithea Therapeutics Corp's market cap is currently ―. The company's EPS TTM is $-15.127; its P/E ratio is -0.38; Pasithea Therapeutics Corp is scheduled to report earnings on March 30, 2022, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.87M$ 4.22M$ -5.15M$ -3.61M$ -3.72M
EBITDA$ -3.70M$ 4.38M$ -4.99M$ -3.45M$ -3.55M
Net Income Common Stockholders$ -3.87M$ -3.86M$ -5.05M$ -3.61M$ -3.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.00M$ 12.00M$ 16.30M$ 19.70M$ 26.77M
Total Assets$ 17.66M$ 22.41M$ 26.12M$ 30.66M$ 38.15M
Total Debt$ 0.00$ 32.99K$ 81.68K$ 385.29K$ 559.10K
Net Debt$ -8.00M$ -11.97M$ -16.22M$ -19.31M$ -26.21M
Total Liabilities$ 1.49M$ 2.52M$ 2.72M$ 2.28M$ 2.56M
Stockholders Equity$ 16.18M$ 19.88M$ 23.40M$ 28.37M$ 35.59M
Cash Flow-
Free Cash Flow$ -4.04M$ -4.32M$ -3.24M$ -2.60M$ -3.47M
Operating Cash Flow$ -4.04M$ -4.32M$ -3.29M$ -2.65M$ -3.50M
Investing Cash Flow--$ 54.54K$ -273.65K$ 344.01K
Financing Cash Flow---$ -3.86M$ -130.77K
Currency in USD

Pasithea Therapeutics Corp Earnings and Revenue History

Pasithea Therapeutics Corp Debt to Assets

Pasithea Therapeutics Corp Cash Flow

Pasithea Therapeutics Corp Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis